PSK (Polysaccharide-K / Krestin)
StrongMechanism of Action
Research Notes
PSK is the most clinically validated mushroom-derived compound in oncology. It was approved by Japan's Ministry of Health in 1977 and has been used in >40 randomized controlled trials involving >12,000 patients. A landmark meta-analysis (Oba et al., 2007, Cancer Science, 8 RCTs, n=8,009) demonstrated that PSK as adjunct to chemotherapy significantly improved 5-year disease-free and overall survival in gastric cancer patients after curative resection. An RCT (Nakazato et al., 1994, The Lancet) showed PSK + chemotherapy improved 5-year survival from 64% to 73% in stage III colorectal cancer. Derived from FRUITING BODY mycelium (Kureha pharmaceutical extraction process).
Found In 1 Herb
3D Molecular Structure
PSK (Polysaccharide-K / Krestin)
Representative pattern: (C₆H₁₀O₅)ₙ
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
